Literature DB >> 1361317

Sulphasalazine inhibition of human granulocyte activation by inhibition of second messenger compounds.

G Carlin1, R Djursäter, G Smedegård.   

Abstract

The effects of sulphasalazine on the production of second messenger compounds in human granulocytes have been characterised by various stimuli. The increases in cytosolic calcium, inositol trisphosphate, diacylglycerol, and phosphatidic acid (all important mediators of intracellular signal transduction) triggered by stimulation were inhibited by sulphasalazine. The metabolites 5-amino-salicylic acid and sulphapyridine were less potent inhibitors than the mother compound. It is concluded that sulphasalazine inhibits the synthesis of phosphoinositide derived second messenger compounds at the level of phospholipase C or its regulatory guanosine 5'-triphosphate (GTP) binding protein. Inhibition of phosphatidic acid synthesis was either due to the same mechanism, or to interaction with a phospholipase D regulating GTP binding protein.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1361317      PMCID: PMC1012461          DOI: 10.1136/ard.51.11.1230

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  33 in total

Review 1.  The regulation and cellular functions of phosphatidylcholine hydrolysis.

Authors:  M M Billah; J C Anthes
Journal:  Biochem J       Date:  1990-07-15       Impact factor: 3.857

2.  Suppressive effect of anti-rheumatic drugs on interleukin-1 beta release from human peripheral blood monocytes.

Authors:  M Okamoto; M Sasano; M Goto; K Nishioka; S Aotsuka; K Nakamura; R Yokohari
Journal:  Int J Immunopharmacol       Date:  1991

3.  Fluoride-mediated activation of the respiratory burst in electropermeabilized neutrophils.

Authors:  P J Hartfield; J M Robinson
Journal:  Biochim Biophys Acta       Date:  1990-09-01

4.  Sulfasalazine inhibition of binding of N-formyl-methionyl-leucyl-phenylalanine (FMLP) to its receptor on human neutrophils.

Authors:  W F Stenson; J Mehta; I Spilberg
Journal:  Biochem Pharmacol       Date:  1984-02-01       Impact factor: 5.858

5.  Inhibition by nonsteroidal anti-inflammatory drugs of superoxide production and granule enzyme release by polymorphonuclear leukocytes stimulated with immune complexes or formyl-methionyl-leucyl-phenylalanine.

Authors:  T M Neal; M C Vissers; C C Winterbourn
Journal:  Biochem Pharmacol       Date:  1987-08-01       Impact factor: 5.858

Review 6.  The role of the neutrophil in rheumatoid arthritis.

Authors:  E Kitsis; G Weissmann
Journal:  Clin Orthop Relat Res       Date:  1991-04       Impact factor: 4.176

Review 7.  Inhibitors of the leukocyte superoxide generating oxidase: mechanisms of action and methods for their elucidation.

Authors:  A R Cross
Journal:  Free Radic Biol Med       Date:  1990       Impact factor: 7.376

Review 8.  Inositol trisphosphate, a novel second messenger in cellular signal transduction.

Authors:  M J Berridge; R F Irvine
Journal:  Nature       Date:  1984 Nov 22-28       Impact factor: 49.962

9.  The effect of sulfasalazine and its active components on human polymorphonuclear leukocyte function in relation to ulcerative colitis.

Authors:  L Molin; O Stendahl
Journal:  Acta Med Scand       Date:  1979

10.  Effect of sulphasalazine and sulphapyridine on neutrophil superoxide production: role of cytosolic free calcium.

Authors:  L Kanerud; I Hafström; B Ringertz
Journal:  Ann Rheum Dis       Date:  1990-05       Impact factor: 19.103

View more
  2 in total

1.  Inhibitory effects of anti-rheumatic drugs on vascular endothelial growth factor in cultured rheumatoid synovial cells.

Authors:  M Nagashima; S Yoshino; H Aono; M Takai; M Sasano
Journal:  Clin Exp Immunol       Date:  1999-05       Impact factor: 4.330

Review 2.  Disease-modifying antirheumatic drugs. Potential effects in older patients.

Authors:  G Gardner; D E Furst
Journal:  Drugs Aging       Date:  1995-12       Impact factor: 3.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.